Study Reveals Benicar® (olmesartan) Linked to Severe Gastrointestinal Problems, Researchers Warn at Digestive Disease Week Conference
PR Web |
A French study involving Benicar® (olmesartan) was recently discussed during the annual Digestive Disease Week (DDW) conference held in
The study, conducted by researchers from the
Benicar® was approved by the
In
Prior to the
"We will fight for the rights of individuals who allege to have experienced serious gastrointestinal injuries after using Benicar®," says
About
The Pharmaceuticals and
If you or a loved one has suffered serious gastrointestinal injuries after using Benicar®, please contact the attorneys at
The choice of a lawyer is an important decision and should not be based solely on advertisements. The cases discussed do not predict outcomes in future cases. Past results afford no guarantee of future results and every case is different and must be judged on its own merits.
Read the full story at http://www.prweb.com/releases/2014/07/prweb11991514.htm
Copyright: | (c) 2014 PRWEB.COM Newswire |
Wordcount: | 847 |
‘Desecrating’ Joan of Arc
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News